Possibility of non-immunosuppressive immunophilin ligands as potential therapeutic agents for Parkinson's disease.
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D000978:Antiparkinson Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D006801:Humans; D020104:Immunophilins / Q000378:metabolism*; D008024:Ligands; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D022021:Tacrolimus Binding Proteins / Q000378:metabolism
D000975:Antioxidants; D000978:Antiparkinson Agents; D008024:Ligands; D018696:Neuroprotective Agents; D022021:Tacrolimus Binding Proteins; D020104:Immunophilins